Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 23.6 | 14.7 | 2.7 | 2.0 | 19.3 | 0.7 | 0.0 | 1.3 | 3.3 | 7.7 |
| 43.5% |
| 1.7 |
| 3.7 |
| 45.5% |
| 3.0 |
| 3.3 |
| 90.0% |
| Last 5 | 5 | 22.2 | 9.8 | 2.6 | 1.4 | 13.8 | 0.4 | 0.0 | 1.0 | 2.2 | 5.6 | 39.3% | 1.2 | 3.4 | 35.3% | 1.8 | 2.0 | 90.0% |
| Last 10 | 10 | 25.0 | 10.3 | 3.3 | 2.1 | 15.7 | 0.6 | 0.5 | 1.0 | 2.5 | 5.3 | 47.2% | 1.3 | 3.3 | 39.4% | 1.4 | 1.6 | 87.5% |
| Last 20 | 20 | 29.7 | 16.1 | 3.9 | 2.7 | 22.7 | 0.8 | 0.3 | 1.6 | 4.5 | 7.8 | 57.3% | 1.3 | 4.5 | 28.9% | 3.2 | 3.9 | 83.1% |
| Season | 75 | 29.4 | 13.4 | 3.6 | 3.3 | 20.3 | 0.9 | 0.4 | 1.8 | 2.8 | 5.0 | 56.8% | 1.7 | 5.1 | 33.4% | 2.7 | 3.2 | 84.0% |
low rim finishing off the ball, low contested shots per minute, low offensive rebounding, high on-ball creation
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 27.9 | 20 | 3 | 5 | 1 | 0 | 2 | 7 | 13 | 53.8% | 4 | 6 | 66.7% | 2 | 2 | 100.0% | 13.0 |
| 2026-04-10 | PHI @ IND | W | 16.4 | 4 | 3 | 1 | 0 | 0 | 1 | 1 | 5 | 20.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -3.0 |
| 2026-04-09 | PHI @ HOU | L | 26.5 | 20 | 2 | 0 | 1 | 0 | 1 | 7 | 16 | 43.8% | 1 | 4 | 25.0% | 5 | 6 | 83.3% | 0.0 |
| 2026-04-06 | PHI @ SAS | L | 22.9 | 5 | 2 | 0 | 0 | 0 | 0 | 2 | 7 | 28.6% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-04-04 | PHI vs. DET | L | 17.4 | 0 | 3 | 1 | 0 | 0 | 1 | 0 | 4 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -8.0 |
| 2026-04-03 | PHI vs. MIN | W | 24.8 | 10 | 4 | 1 | 0 | 2 | 0 | 5 | 8 | 62.5% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | 9.0 |
| 2026-04-01 | PHI @ WAS | W | 23.1 | 12 | 4 | 1 | 0 | 0 | 2 | 5 | 10 | 50.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -13.0 |
| 2026-03-30 | PHI @ MIA | L | 31.6 | 11 | 5 | 4 | 0 | 0 | 1 | 4 | 8 | 50.0% | 2 | 5 | 40.0% | 1 | 2 | 50.0% | 12.0 |
| 2026-03-28 | PHI @ CHA | W | 28.5 | 8 | 1 | 3 | 1 | 0 | 1 | 2 | 5 | 40.0% | 2 | 3 | 66.7% | 2 | 2 | 100.0% | 13.0 |
| 2026-03-25 | PHI vs. CHI | W | 31.0 | 13 | 6 | 5 | 3 | 3 | 1 | 5 | 10 | 50.0% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | 16.0 |
| 2026-03-21 | PHI @ UTA | W | 35.6 | 25 | 5 | 4 | 0 | 0 | 4 | 9 | 15 | 60.0% | 1 | 4 | 25.0% | 6 | 6 | 100.0% | 9.0 |
| 2026-03-19 | PHI @ SAC | W | 31.8 | 27 | 5 | 7 | 0 | 0 | 1 | 10 | 20 | 50.0% | 3 | 6 | 50.0% | 4 | 6 | 66.7% | 11.0 |
| 2026-03-17 | PHI @ DEN | L | 26.3 | 12 | 2 | 1 | 0 | 0 | 2 | 5 | 12 | 41.7% | 1 | 5 | 20.0% | 1 | 2 | 50.0% | -21.0 |
| 2026-03-15 | PHI vs. POR | W | 39.5 | 31 | 3 | 2 | 3 | 1 | 1 | 11 | 22 | 50.0% | 1 | 4 | 25.0% | 8 | 8 | 100.0% | 7.0 |
| 2026-03-14 | PHI vs. BKN | W | 34.1 | 28 | 8 | 4 | 1 | 0 | 2 | 10 | 22 | 45.5% | 1 | 6 | 16.7% | 7 | 7 | 100.0% | 13.0 |
| 2026-03-12 | PHI @ DET | L | 32.1 | 14 | 3 | 5 | 1 | 1 | 3 | 5 | 14 | 35.7% | 1 | 8 | 12.5% | 3 | 6 | 50.0% | -28.0 |
| 2026-03-10 | PHI vs. MEM | W | 35.5 | 23 | 3 | 2 | 2 | 0 | 2 | 6 | 16 | 37.5% | 0 | 4 | 0.0% | 11 | 13 | 84.6% | 11.0 |
| 2026-03-09 | PHI @ CLE | L | 36.1 | 17 | 5 | 3 | 0 | 0 | 1 | 6 | 13 | 46.2% | 2 | 8 | 25.0% | 3 | 3 | 100.0% | -21.0 |
| 2026-03-07 | PHI @ ATL | L | 41.2 | 26 | 6 | 3 | 1 | 0 | 4 | 9 | 15 | 60.0% | 3 | 8 | 37.5% | 5 | 7 | 71.4% | -13.0 |
| 2026-03-04 | PHI vs. UTA | W | 31.1 | 16 | 5 | 2 | 1 | 0 | 3 | 7 | 12 | 58.3% | 0 | 4 | 0.0% | 2 | 3 | 66.7% | 4.0 |
| 2026-03-03 | PHI vs. SAS | L | 21.8 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 5 | 20.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -34.0 |
| 2026-03-01 | PHI @ BOS | L | 26.6 | 5 | 1 | 2 | 0 | 0 | 0 | 2 | 5 | 40.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -14.0 |
| 2026-02-26 | PHI vs. MIA | W | 21.0 | 9 | 4 | 0 | 0 | 0 | 4 | 3 | 8 | 37.5% | 3 | 7 | 42.9% | 0 | 0 | 0.0% | -1.0 |
| 2026-02-24 | PHI @ IND | W | 26.5 | 15 | 2 | 2 | 2 | 0 | 1 | 6 | 11 | 54.5% | 1 | 4 | 25.0% | 2 | 3 | 66.7% | 26.0 |
| 2026-02-22 | PHI @ MIN | W | 27.6 | 19 | 3 | 7 | 1 | 0 | 1 | 7 | 12 | 58.3% | 5 | 8 | 62.5% | 0 | 0 | 0.0% | 18.0 |
| 2026-02-21 | PHI @ NOP | L | 25.8 | 11 | 1 | 3 | 0 | 1 | 1 | 3 | 9 | 33.3% | 2 | 7 | 28.6% | 3 | 4 | 75.0% | -16.0 |
| 2026-02-19 | PHI vs. ATL | L | 28.9 | 14 | 2 | 1 | 0 | 1 | 2 | 5 | 9 | 55.6% | 2 | 4 | 50.0% | 2 | 4 | 50.0% | -3.0 |
| 2026-02-07 | PHI @ PHX | W | 28.2 | 6 | 4 | 3 | 0 | 0 | 2 | 2 | 4 | 50.0% | 0 | 1 | 0.0% | 2 | 3 | 66.7% | 2.0 |
| 2026-02-05 | PHI @ LAL | L | 27.4 | 4 | 0 | 2 | 1 | 0 | 2 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | -10.0 |
| 2026-02-03 | PHI @ GSW | W | 23.2 | 10 | 5 | 3 | 1 | 0 | 1 | 4 | 9 | 44.4% | 2 | 6 | 33.3% | 0 | 0 | 0.0% | 7.0 |
| 2026-02-02 | PHI @ LAC | W | 27.8 | 14 | 2 | 4 | 0 | 0 | 0 | 5 | 8 | 62.5% | 2 | 5 | 40.0% | 2 | 2 | 100.0% | 4.0 |
| 2026-01-31 | PHI vs. NOP | W | 15.8 | 4 | 4 | 2 | 0 | 0 | 0 | 2 | 3 | 66.7% | 0 | 1 | 0.0% | 0 | 0 | 0.0% | -3.0 |
| 2026-01-26 | PHI @ CHA | L | 26.2 | 14 | 3 | 5 | 1 | 0 | 2 | 5 | 11 | 45.5% | 0 | 2 | 0.0% | 4 | 5 | 80.0% | -7.0 |
| 2026-01-24 | PHI vs. NYK | L | 18.9 | 4 | 3 | 3 | 0 | 1 | 0 | 2 | 6 | 33.3% | 0 | 4 | 0.0% | 0 | 0 | 0.0% | 0.0 |
| 2026-01-22 | PHI vs. HOU | W | 19.1 | 3 | 1 | 3 | 1 | 0 | 1 | 1 | 2 | 50.0% | 0 | 1 | 0.0% | 1 | 1 | 100.0% | -11.0 |
| 2026-01-20 | PHI vs. PHX | L | 26.9 | 12 | 4 | 5 | 3 | 0 | 3 | 3 | 7 | 42.9% | 1 | 3 | 33.3% | 5 | 6 | 83.3% | -11.0 |
| 2026-01-19 | PHI vs. IND | W | 20.0 | 5 | 3 | 1 | 1 | 0 | 1 | 1 | 7 | 14.3% | 0 | 3 | 0.0% | 3 | 4 | 75.0% | 8.0 |
| 2026-01-16 | PHI vs. CLE | L | 31.5 | 14 | 7 | 4 | 0 | 0 | 0 | 5 | 12 | 41.7% | 2 | 7 | 28.6% | 2 | 3 | 66.7% | -4.0 |
| 2026-01-14 | PHI vs. CLE | L | 22.1 | 8 | 5 | 0 | 1 | 0 | 1 | 3 | 7 | 42.9% | 2 | 5 | 40.0% | 0 | 0 | 0.0% | -10.0 |
| 2026-01-12 | PHI @ TOR | W | 15.6 | 6 | 4 | 2 | 0 | 0 | 1 | 2 | 3 | 66.7% | 1 | 2 | 50.0% | 1 | 1 | 100.0% | 4.0 |
| 2026-01-11 | PHI @ TOR | L | 34.7 | 13 | 7 | 1 | 1 | 0 | 4 | 4 | 9 | 44.4% | 1 | 4 | 25.0% | 4 | 5 | 80.0% | 4.0 |
| 2026-01-09 | PHI @ ORL | W | 28.6 | 6 | 1 | 3 | 1 | 1 | 1 | 2 | 5 | 40.0% | 1 | 4 | 25.0% | 1 | 1 | 100.0% | 11.0 |
| 2026-01-07 | PHI vs. WAS | W | 26.3 | 16 | 1 | 1 | 2 | 0 | 2 | 5 | 9 | 55.6% | 1 | 3 | 33.3% | 5 | 5 | 100.0% | -1.0 |
| 2026-01-05 | PHI vs. DEN | L | 39.6 | 16 | 4 | 2 | 0 | 1 | 2 | 4 | 8 | 50.0% | 3 | 7 | 42.9% | 5 | 6 | 83.3% | 9.0 |
| 2026-01-03 | PHI @ NYK | W | 33.8 | 10 | 6 | 5 | 3 | 2 | 1 | 4 | 10 | 40.0% | 2 | 7 | 28.6% | 0 | 0 | 0.0% | 4.0 |
| 2026-01-01 | PHI @ DAL | W | 38.5 | 19 | 7 | 2 | 1 | 3 | 0 | 7 | 9 | 77.8% | 5 | 7 | 71.4% | 0 | 0 | 0.0% | 19.0 |
| 2025-12-30 | PHI @ MEM | W | 37.5 | 11 | 3 | 3 | 3 | 0 | 0 | 4 | 9 | 44.4% | 2 | 6 | 33.3% | 1 | 2 | 50.0% | 18.0 |
| 2025-12-28 | PHI @ OKC | L | 22.4 | 13 | 2 | 3 | 0 | 0 | 1 | 3 | 10 | 30.0% | 3 | 9 | 33.3% | 4 | 4 | 100.0% | -22.0 |
| 2025-12-26 | PHI @ CHI | L | 25.9 | 2 | 1 | 2 | 0 | 0 | 0 | 1 | 4 | 25.0% | 0 | 3 | 0.0% | 0 | 0 | 0.0% | -21.0 |
| 2025-12-20 | PHI vs. DAL | W | 24.6 | 6 | 2 | 7 | 2 | 0 | 1 | 2 | 9 | 22.2% | 0 | 3 | 0.0% | 2 | 2 | 100.0% | -8.0 |
| 2025-12-19 | PHI @ NYK | W | 17.8 | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 4 | 25.0% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | -4.0 |
| 2025-12-14 | PHI @ ATL | L | 38.6 | 14 | 2 | 7 | 2 | 0 | 2 | 4 | 14 | 28.6% | 4 | 10 | 40.0% | 2 | 2 | 100.0% | -5.0 |
| 2025-12-12 | PHI vs. IND | W | 38.9 | 10 | 9 | 4 | 1 | 1 | 1 | 3 | 9 | 33.3% | 2 | 7 | 28.6% | 2 | 2 | 100.0% | 13.0 |
| 2025-12-07 | PHI vs. LAL | L | 29.3 | 7 | 8 | 3 | 0 | 0 | 0 | 2 | 7 | 28.6% | 1 | 6 | 16.7% | 2 | 2 | 100.0% | 1.0 |
| 2025-12-05 | PHI @ MIL | W | 28.8 | 22 | 4 | 5 | 0 | 0 | 5 | 7 | 9 | 77.8% | 6 | 7 | 85.7% | 2 | 2 | 100.0% | 15.0 |
| 2025-12-04 | PHI vs. GSW | W | 38.0 | 12 | 5 | 6 | 1 | 0 | 1 | 5 | 13 | 38.5% | 0 | 5 | 0.0% | 2 | 3 | 66.7% | 5.0 |
| 2025-11-30 | PHI vs. ATL | L | 46.7 | 28 | 10 | 4 | 2 | 0 | 3 | 8 | 15 | 53.3% | 4 | 8 | 50.0% | 8 | 8 | 100.0% | 2.0 |
| 2025-11-28 | PHI @ BKN | W | 42.6 | 19 | 3 | 9 | 2 | 0 | 5 | 8 | 20 | 40.0% | 0 | 6 | 0.0% | 3 | 4 | 75.0% | 5.0 |
| 2025-11-25 | PHI vs. ORL | L | 26.9 | 8 | 3 | 4 | 0 | 0 | 3 | 1 | 9 | 11.1% | 0 | 4 | 0.0% | 6 | 6 | 100.0% | -34.0 |
| 2025-11-23 | PHI vs. MIA | L | 34.9 | 15 | 0 | 3 | 0 | 1 | 2 | 6 | 14 | 42.9% | 2 | 7 | 28.6% | 1 | 1 | 100.0% | -12.0 |
| 2025-11-20 | PHI @ MIL | W | 38.8 | 14 | 4 | 4 | 0 | 0 | 1 | 4 | 12 | 33.3% | 3 | 9 | 33.3% | 3 | 4 | 75.0% | 8.0 |
| 2025-11-19 | PHI vs. TOR | L | 31.9 | 21 | 2 | 2 | 2 | 0 | 1 | 7 | 15 | 46.7% | 4 | 8 | 50.0% | 3 | 3 | 100.0% | -5.0 |
| 2025-11-17 | PHI vs. LAC | W | 35.6 | 19 | 2 | 3 | 1 | 2 | 0 | 6 | 10 | 60.0% | 3 | 6 | 50.0% | 4 | 5 | 80.0% | 12.0 |
| 2025-11-14 | PHI @ DET | L | 32.4 | 9 | 1 | 5 | 1 | 1 | 2 | 3 | 10 | 30.0% | 1 | 5 | 20.0% | 2 | 2 | 100.0% | 6.0 |
| 2025-11-11 | PHI vs. BOS | W | 27.8 | 18 | 6 | 4 | 0 | 1 | 4 | 6 | 10 | 60.0% | 3 | 6 | 50.0% | 3 | 3 | 100.0% | 0.0 |
| 2025-11-09 | PHI vs. DET | L | 29.7 | 13 | 5 | 4 | 1 | 0 | 3 | 4 | 8 | 50.0% | 2 | 5 | 40.0% | 3 | 3 | 100.0% | -7.0 |
| 2025-11-08 | PHI vs. TOR | W | 27.8 | 13 | 2 | 2 | 0 | 0 | 3 | 4 | 8 | 50.0% | 3 | 6 | 50.0% | 2 | 2 | 100.0% | 2.0 |
| 2025-11-05 | PHI @ CLE | L | 32.0 | 27 | 3 | 3 | 0 | 0 | 4 | 9 | 15 | 60.0% | 1 | 5 | 20.0% | 8 | 9 | 88.9% | 4.0 |
| 2025-11-04 | PHI @ CHI | L | 29.6 | 10 | 3 | 4 | 4 | 1 | 4 | 4 | 11 | 36.4% | 0 | 5 | 0.0% | 2 | 3 | 66.7% | -13.0 |
| 2025-11-02 | PHI @ BKN | W | 31.7 | 22 | 6 | 13 | 1 | 1 | 4 | 7 | 13 | 53.8% | 4 | 8 | 50.0% | 4 | 6 | 66.7% | 32.0 |
| 2025-10-31 | PHI vs. BOS | L | 33.2 | 16 | 2 | 3 | 1 | 0 | 3 | 6 | 13 | 46.2% | 2 | 7 | 28.6% | 2 | 4 | 50.0% | -15.0 |
| 2025-10-28 | PHI @ WAS | W | 38.8 | 23 | 7 | 3 | 3 | 2 | 2 | 7 | 17 | 41.2% | 3 | 10 | 30.0% | 6 | 6 | 100.0% | 19.0 |
| 2025-10-27 | PHI vs. ORL | W | 25.8 | 14 | 5 | 3 | 0 | 0 | 2 | 3 | 8 | 37.5% | 3 | 4 | 75.0% | 5 | 6 | 83.3% | 4.0 |
| 2025-10-25 | PHI vs. CHA | W | 30.3 | 24 | 3 | 4 | 0 | 0 | 2 | 7 | 14 | 50.0% | 5 | 8 | 62.5% | 5 | 5 | 100.0% | -5.0 |
| 2025-10-22 | PHI @ BOS | W | 31.6 | 10 | 5 | 5 | 0 | 0 | 5 | 3 | 8 | 37.5% | 2 | 5 | 40.0% | 2 | 4 | 50.0% | 18.0 |